Summary & Overview
HCPCS J2798: Risperidone (Perseris) Injection, 0.5 mg
HCPCS Level II code J2798 identifies the injectable formulation of risperidone (Perseris) at a 0.5 mg unit. This medication is a long-acting injectable antipsychotic used in the treatment of certain psychiatric disorders; the code captures the drug administration component for billing and coverage purposes. Nationally, such specialty injectable drug codes are important for payer coverage determinations, site-of-service billing, and cost management for behavioral health treatments.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for J2798, the typical sites of service where the injection is administered, and the elements that commonly affect billing for specialty injectable antipsychotics. The report highlights benchmark considerations, payer coverage patterns, and recent policy or coding guidance relevant to injectable antipsychotic medications where available.
This summary provides clinicians, billing professionals, and policy analysts with the essential framing for J2798: what the code represents, why it matters in national payer landscapes, and what topics are covered in the full publication, including reimbursement benchmarking, coverage policy notes, and clinical service context. Data not available in the input are noted where applicable.
Billing Code Overview
HCPCS Level II code J2798 describes an injection of risperidone (Perseris) at a dosage unit of 0.5 mg. The code corresponds to the drug administration itself rather than a visit or procedure.
Service Type: Long-acting injectable antipsychotic medication administration
Typical Site of Service: Outpatient clinic, behavioral health clinic, or ambulatory infusion/medication administration center
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with schizophrenia or schizoaffective disorder who has a history of poor adherence to oral antipsychotic therapy and requires long‑acting, subcutaneous risperidone (Perseris) for maintenance treatment. The patient presents to an outpatient behavioral health clinic or ambulatory infusion/medication administration suite. A psychiatric nurse or behavioral health clinician verifies identity, reviews recent medication and allergy history, assesses current psychiatric stability and injection-site integrity, obtains informed consent for treatment, and documents baseline mental status and vitals. The clinician prepares J2798 (injection, risperidone, Perseris, 0.5 mg) per product instructions, performs antiseptic skin prep of the subcutaneous site (typically abdomen or upper arm), administers the single-dose subcutaneous injection, and observes the patient for immediate adverse reactions for 15–30 minutes. Post-injection documentation includes lot number, expiration date, dose administered, injection site, patient tolerance, and scheduling of the next monthly dose. Typical sites of service are outpatient behavioral health clinics, physician offices (psychiatry), community mental health centers, and ambulatory infusion centers.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Procedure performed; no modifier required | Rarely appended; represents standard unmodified service when payer accepts base code |
11 | Primary procedure | When J2798 is the primary billed service on the claim for that visit |
22 | Increased procedural services | When additional work beyond typical administration occurs (e.g., extended monitoring for adverse reaction) |
23 | Unusual anesthesia | Not commonly used for this injection; would apply if unexpected anesthesia was required during administration |
52 | Reduced services | When a partial dose or abbreviated administration occurs (e.g., patient received a partial vial due to intolerance) |
53 | Discontinued procedure | If administration was started but stopped prior to completion for medical reasons |
62 | Two surgeons — distinct procedural roles | Rare for this service; applicable if two practitioners with distinct roles are required during administration |
78 | Return to operating/procedure room for related procedure | Uncommon; used if patient requires repeat immediate intervention related to the injection procedure |
80 | Assistant surgeon | Not typically applicable; included only when an assistant surgeon is documented for the visit |
JW | Drug discarded/unused portion discarded | When billed drug was partially used and the discarded amount must be reported per payer policy for single‑use vial waste documentation |
JZ | No drug wasted — full amount administered | When the exact billed amount of J2798 was fully administered with no discard |
QX | Certified registered nurse anesthetist (CRNA) services with modifier QK/QY pairing rules | Included here for completeness though rarely used for this type of injection; applies when CRNA provides anesthesia services per payer rules |
QY | Medical direction of two or more CRNAs | As above, rarely applicable for subcutaneous antipsychotic injection |
JW | Single‑use vial discarded — documentation of wasted medication (duplicate listing omitted) | See above for JW guidance |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
207P00000X | Psychiatry & Neurology | Psychiatrists prescribe and oversee long‑acting injectable antipsychotic therapy |
363L00000X | Nursing — Psychiatry & Mental Health | Registered nurses in behavioral health commonly administer monthly injections and perform monitoring |
261QM0800X | Ambulatory Mental Health Service Provider | Clinicians in community mental health centers who manage medication clinics |
2084P0800X | Clinical Social Worker | May coordinate medication delivery and perform follow‑up but do not typically administer injectables in all jurisdictions |
182200000X | Pharmacist | Pharmacists prepare and verify injectable doses in clinic or infusion settings where permitted |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
F20.9 | Schizophrenia, unspecified | Schizophrenia is a primary indication for long‑acting injectable risperidone to improve adherence and reduce relapse risk |
F25.9 | Schizoaffective disorder, unspecified | Schizoaffective disorder is commonly managed with antipsychotic maintenance therapy, including long‑acting injectables |
F31.9 | Bipolar disorder, unspecified | Some patients with bipolar disorder and prominent psychotic features or adherence challenges may receive long‑acting antipsychotics |
F32.9 | Major depressive disorder, single episode, unspecified | Not a primary indication but may be present as comorbidity; antipsychotic therapy occasionally used as augmentation in treatment‑resistant cases |
Z79.899 | Other long term (current) drug therapy | Used to indicate chronic outpatient medication therapy management when documenting maintenance injectable antipsychotic use |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
96372 | Therapeutic, prophylactic, or diagnostic injection (subcutaneous or intramuscular); single or initial substance/drug | Commonly used to report the actual administration service when payers require a CPT administration code in addition to the J‑code for drug supply; documents the injection procedure itself |
99212 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | Typical E/M visit level for follow‑up medication visits where J2798 is administered and brief assessment is performed |
99213 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | Used when medication management requires moderate complexity decision‑making or longer counseling during the same visit as administration |
96401 | Chemotherapy administration, subcutaneous or intramuscular; non‑chemotherapeutic drugs, single injection | Occasionally used by some payers for reporting subcutaneous non‑chemotherapy drug administration when 96372 is not accepted; verify payer policy |
99070 | Supplies and materials (e.g., sterile trays, syringes) used for procedures, not usually billed separately when included by payer | Used if the clinic must separately bill for noncovered supplies associated with injection per payer rules |